VASVX | VMVAX | VASVX / VMVAX | |
Total Expense Ratio | 0.42 | 0.07 | 600% |
Annual Report Gross Expense Ratio | 0.42 | 0.07 | 600% |
Fund Existence | 30 years | 14 years | - |
Gain YTD | 6.135 | 5.198 | 118% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 3000 | 3000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.18B | 31B | 20% |
Annual Yield % from dividends | 1.73 | 2.22 | 78% |
Returns for 1 year | -6.84 | 7.67 | -89% |
Returns for 3 years | -1.98 | 17.51 | -11% |
Returns for 5 years | 22.42 | 65.15 | 34% |
Returns for 10 years | -0.02 | 87.87 | -0% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
IREIX | 15.45 | 0.07 | +0.46% |
Macquarie Real Estate Securities I | |||
VEUPX | 187.88 | 0.29 | +0.15% |
Vanguard European Stock Instl Plus | |||
ALMCX | 7.30 | N/A | N/A |
Alger Weatherbie Specialized Growth C | |||
MRLRX | 19.08 | -0.05 | -0.26% |
BlackRock Advantage Large Cap Core R | |||
BSMKX | 17.50 | -0.08 | -0.46% |
iShares Russell Small/Mid-Cap Idx K |